跳至主要内容
临床试验/NCT05014282
NCT05014282进行中(未招募)不适用

Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living With HIV (Project RESOURCE)

H. Lee Moffitt Cancer Center and Research Institute1 个研究点 分布在 1 个国家目标入组 512 人开始时间: 2021年12月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
512
试验地点
1
主要终点
Self-Reported 7-Day Point-Prevalence Smoking Abstinence

研究概览

简要总结

This study evaluates whether Automated Treatment performed better, in terms of facilitating long-term smoking abstinence, than the more resource-intensive Standard Treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •smoked >/=100 cigarettes in lifetime
  • •English or Spanish speaking
  • •Currently smoke > 5 cigarettes/day
  • •Willing to make a quit attempt within 1 week of enrollment
  • •HIV positive
  • •Process a smartphone compatible with the project app
  • •Have a valid email address

排除标准

  • •Currently pregnant or breastfeeding
  • •Current use of smoking cessation medications
  • •Enrolled in a smoking cessation study
  • •Household member enrolled in the study
  • •Failure to electronically confirm participation within 14 days of randomization via electronic link sent to participant's smartphone

研究组 & 干预措施

Standard Treatment

Active Comparator

Participants randomized to Standard Treatment (ST) were provided with a 10-week supply of nicotine patches and lozenges. ST participants were connected with their state's Quitline services to receive smoking cessation treatment.

干预措施: Nicotine patch (Drug)

Standard Treatment

Active Comparator

Participants randomized to Standard Treatment (ST) were provided with a 10-week supply of nicotine patches and lozenges. ST participants were connected with their state's Quitline services to receive smoking cessation treatment.

干预措施: Nicotine lozenge (Drug)

Automated Treatment

Experimental

Participants randomized to Automated Treatment (AT) were given a 10-week supply of nicotine patches and lozenges. AT comprised: 1) 12 proactive video-based treatment sessions, delivered weekly, that were tailored on smoking status, motivation, agency, and negative affect/stress; 2) 26 weeks of on-demand access to treatment content tailored on smoking status, motivation, agency, and negative affect/stress; 3) 26 weeks of text content.

干预措施: Nicotine patch (Drug)

Automated Treatment

Experimental

Participants randomized to Automated Treatment (AT) were given a 10-week supply of nicotine patches and lozenges. AT comprised: 1) 12 proactive video-based treatment sessions, delivered weekly, that were tailored on smoking status, motivation, agency, and negative affect/stress; 2) 26 weeks of on-demand access to treatment content tailored on smoking status, motivation, agency, and negative affect/stress; 3) 26 weeks of text content.

干预措施: Nicotine lozenge (Drug)

Standard Treatment

Active Comparator

Participants randomized to Standard Treatment (ST) were provided with a 10-week supply of nicotine patches and lozenges. ST participants were connected with their state's Quitline services to receive smoking cessation treatment.

干预措施: Counseling (Behavioral)

Automated Treatment

Experimental

Participants randomized to Automated Treatment (AT) were given a 10-week supply of nicotine patches and lozenges. AT comprised: 1) 12 proactive video-based treatment sessions, delivered weekly, that were tailored on smoking status, motivation, agency, and negative affect/stress; 2) 26 weeks of on-demand access to treatment content tailored on smoking status, motivation, agency, and negative affect/stress; 3) 26 weeks of text content.

干预措施: Smartphone-delivered automated treatment (Behavioral)

结局指标

主要结局

Self-Reported 7-Day Point-Prevalence Smoking Abstinence

时间窗: 12 Month Follow-Up

Participants who reported no smoking, not even a puff, within the past 7 days.

Self Reported 7 Day Abstinence Smoking Status

时间窗: 12 Month Follow-Up

Participants will self report 7-day abstinence smoking status

次要结局

  • Biochemical Verification Via Salivary Cotinine(12 Month Follow-Up)
  • Self-Reported 30-Day Point-Prevalence Smoking Abstinence(12 Month Follow-Up)
  • Continuous Smoking Abstinence(12 Month Follow-Up)
  • Smoking Status by Saliva Cotinine Kit(12 Month Follow-Up)
  • Self Reported 24 Hours Smoking Abstinence(12 Month Follow-Up)
  • 30 Day Smoking Abstinence(12 Month Follow-Up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验